Bimatoprost is an artificial prostaglandin analog, which is a type of drug that resembles the action of the naturally occurring prostaglandins. It is mainly used in two different clinical sectors, namely, ophthalmology and dermatology. Its effectiveness derives through a given mechanism of action and although it has a good interaction profile, there are some considerations to take into consideration.
The drug's effects are mediated through the prostaglandin F (FP) receptors, though its precise molecular actions are not fully identical to endogenous prostaglandins and may involve additional pathways.
Bimatoprost, particularly in its topical ophthalmic form, has a relatively low systemic absorption and a low risk of significant pharmacological drug interactions. However, several important considerations exist:
Common side effects are localized and include conjunctival hyperaemia , eyelash growth, periocular skin darkening, iris pigmentation changes and ocular itching or irritation. Systemic side effects are uncommon but can include headaches and, very rarely, exacerbation of asthma or uveitis.
To sum it up, bimatoprost is a multi-purpose prostaglandin analogue that has found the most implications in glaucoma treatment due to its ability to stimulate uveoscleral outflow, and hair loss treatment and aesthetics due to its effect on hair follicles. Drug interaction risks are reduced in its systemic absorption as it is a well-tolerated and effective drug in its uses.